Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms
暂无分享,去创建一个
Nicholas J. Jacobs | D. Hogan | S. Rajamani | J. Cubillos-Ruiz | D. K. Morales | Malathy Krishnamurthy | J. Cubillos-Ruiz
[1] K. Bennett,et al. Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis. , 2010, Chest.
[2] D. Hogan,et al. Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains , 2010, Microbiology.
[3] D. Hogan,et al. Candida albicans Interactions with Bacteria in the Context of Human Health and Disease , 2010, PLoS pathogens.
[4] Deborah A. Hogan,et al. Medically important bacterial–fungal interactions , 2010, Nature Reviews Microbiology.
[5] D. Hogan,et al. Farnesol Induces Hydrogen Peroxide Resistance in Candida albicans Yeast by Inhibiting the Ras-Cyclic AMP Signaling Pathway , 2010, Eukaryotic Cell.
[6] B. Peters,et al. Cross-kingdom interactions: Candida albicans and bacteria. , 2009, FEMS microbiology letters.
[7] M. Muller,et al. Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1. , 2009, Free radical biology & medicine.
[8] D. Hogan,et al. Pseudomonas aeruginosa-Candida albicans Interactions: Localization and Fungal Toxicity of a Phenazine Derivative , 2008, Applied and Environmental Microbiology.
[9] N. Gow,et al. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa , 2008, FEMS microbiology letters.
[10] G. Robertson,et al. Bacterial and fungal biofilm infections. , 2008, Annual review of medicine.
[11] D. Hogan,et al. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa , 2007, Molecular microbiology.
[12] Dianne K. Newman,et al. Pyocyanin Alters Redox Homeostasis and Carbon Flux through Central Metabolic Pathways in Pseudomonas aeruginosa PA14 , 2007, Journal of bacteriology.
[13] Alistair J. P. Brown,et al. Niche-Specific Activation of the Oxidative Stress Response by the Pathogenic Fungus Candida albicans , 2007, Infection and Immunity.
[14] Bryan T Greenhagen,et al. Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosa. , 2007, Biochemistry.
[15] V. Tikhonov,et al. Oxidation-induced calcium-dependent dehydration of normal human red blood cells , 2007, Free radical research.
[16] W. Blankenfeldt,et al. Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. , 2006, Annual review of phytopathology.
[17] K. Ying,et al. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. , 2006, Free radical biology & medicine.
[18] D. Newman,et al. Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics , 2006, Nature chemical biology.
[19] Brice Enjalbert,et al. Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. , 2005, Molecular biology of the cell.
[20] R. Prasad,et al. Interactions between bacteria and Candida in the burn wound. , 2005, Burns : journal of the International Society for Burn Injuries.
[21] R. Kolter,et al. A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.
[22] D. Hassett,et al. The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.
[23] D. Hassett,et al. Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.
[24] N. Gow,et al. GFP as a quantitative reporter of gene regulation in Candida albicans , 2004, Yeast.
[25] D. Hassett,et al. Human targets of Pseudomonas aeruginosa pyocyanin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Lamers,et al. Interactions in the tomato rhizosphere of two Pseudomonas biocontrol strains with the phytopathogenic fungus Fusarium oxysporum f. sp. radicis-lycopersici. , 2003, Molecular plant-microbe interactions : MPMI.
[27] M. Muller,et al. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. , 2002, Free radical biology & medicine.
[28] R. Kolter,et al. Pseudomonas-Candida Interactions: An Ecological Role for Virulence Factors , 2002, Science.
[29] G. Taylor,et al. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. , 1999, Journal of clinical pathology.
[30] Frederick M. Ausubel,et al. Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas aeruginosa– Caenorhabditis elegans Pathogenesis Model , 1999, Cell.
[31] N. Koedam,et al. Involvement of phenazines and anthranilate in the antagonism of Pseudomonas aeruginosa PNA1 and Tn5 derivatives toward Fusarium spp. and Pythium spp. , 1998 .
[32] L. Anderson,et al. Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation , 1998, Oncogene.
[33] S. Austin,et al. Electron donation to the flavoprotein NifL, a redox-sensing transcriptional regulator. , 1998, The Biochemical journal.
[34] C. Vandenbroucke-Grauls,et al. Helicobacter pylori ribBA-Mediated Riboflavin Production Is Involved in Iron Acquisition , 1998, Journal of bacteriology.
[35] J. Kerr. Suppression of fungal growth exhibited by Pseudomonas aeruginosa , 1994, Journal of clinical microbiology.
[36] L. Thomashow,et al. Production of the Antibiotic Phenazine-1-Carboxylic Acid by Fluorescent Pseudomonas Species in the Rhizosphere of Wheat , 1990, Applied and environmental microbiology.
[37] L. Thomashow,et al. Role of a phenazine antibiotic from Pseudomonas fluorescens in biological control of Gaeumannomyces graminis var. tritici , 1988, Journal of bacteriology.
[38] A. Bauernfeind,et al. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis , 1987, Infection.
[39] G. Bellomo,et al. Cytotoxicity of phenazine methosulfate in isolated rat hepatocytes is associated with superoxide anion production, thiol oxidation and alterations in intracellular calcium ion homeostasis. , 1986, Toxicology letters.
[40] J. García-Sancho,et al. Effects of redox agents on the Ca2+-activated K+ channel. , 1983, Cell calcium.
[41] G. Babcock,et al. Properties of 5-methylphenazinium methyl sulfate. Reaction of the oxidized form with NADH and of the reduced form with oxygen. , 1982, The Journal of biological chemistry.
[42] S. Baron,et al. Antibiotic action of pyocyanin , 1981, Antimicrobial Agents and Chemotherapy.
[43] I. Fridovich,et al. Mechanism of the antibiotic action pyocyanine , 1980, Journal of bacteriology.
[44] R. Jensen,et al. Biosynthesis of phenazine pigments in mutant and wild-type cultures of Pseudomonas aeruginosa , 1979, Journal of bacteriology.
[45] Ho Kyun Kim,et al. Mycoflora in cystic fibrosis: Some ecologic aspects of pseudomonas aeruginosa and Candida albicans , 1973, Mycopathologia et mycologia applicata.
[46] S. French,et al. Phenazine methosulfate uptake by rat liver mitochondria. , 1973, Canadian journal of biochemistry.
[47] K. Yagi,et al. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. , 1972, Biochemical and biophysical research communications.
[48] W. Konings,et al. Mechanisms of active transport in isolated membrane vesicles. 2. The coupling of reduced phenazine methosulfate to the concentrative uptake of beta-galactosides and amino acids. , 1971, The Journal of biological chemistry.
[49] H. Kaback,et al. Mechanisms of active transport in isolated membrane vesicles. II. The mechanism of energy coupling between D-lactic dehydrogenase and beta-galactoside transport in membrane preparations from Escherichia coli. , 1971, The Journal of biological chemistry.
[50] J. Ottaway. Some rate constants for the phenazine methosulphate-catalysed oxidation of reduced nicotinamide-adenine dinucleotide. , 1966, The Biochemical journal.
[51] W. S. Zaugg. SPECTROSCOPIC CHARACTERISTICS AND SOME CHEMICAL PROPERTIES OF N-METHYLPHENAZINIUM METHYL SULFATE (PHENAZINE METHOSULFATE) AND PYOCYANINE AT THE SEMIQUIDNOID OXIDATION LEVEL. , 1964, The Journal of biological chemistry.
[52] R. Steele,et al. A chemiluminescence (CL) of phenazine methosulfate (PMS) in the presence of hydrogen peroxide (HOOH) induced by reductants including reduced nicotinamide adenine dinucleotide (NADH) and ascorbic acid (AA). , 1963, Biochemical and biophysical research communications.
[53] K. Rajagopalan,et al. Oxidation of phenazine methosulfate by hepatic aldehyde oxidase. , 1962, Biochemical and biophysical research communications.
[54] L. J. Douglas,et al. Candida biofilms and their role in infection. , 2003, Trends in microbiology.
[55] Alan R. Katritzky,et al. Handbook of heterocyclic chemistry , 1985 .
[56] S. Petrova,et al. Electrochemical properties of flavins in aqueous solutions , 1983 .
[57] W. Konings,et al. Site of interaction between phenazine methosulphate and the respiratory chain of Bacillus subtilis. , 1979, European journal of biochemistry.
[58] R. Herbert,et al. Pigments of Pseudomonas species. IV. In vitro and in vivo conversion of 5-methylphenazinium-1-carboxylate into aeruginosin A. , 1972, Journal of the Chemical Society. Perkin transactions 1.
[59] R. Herbert,et al. Pigments of pseudomonas species. II. Structure of aeruginosin B. , 1969, Journal of the Chemical Society. Perkin transactions 1.
[60] F. G. Holliman. Pigments of Pseudomonas species. Part I. Structure and synthesis of aeruginosin A , 1969 .
[61] R. Herbert,et al. Pigments of Pseudomonas species. Part II. Structure of aeruginosin B , 1969 .
[62] F. G. Holliman. Pigments of pseudomonas species. I. Structure and synthesis of aeruginosin A. , 1969, Journal of the Chemical Society. Perkin transactions 1.
[63] H. Mcilwain. 359. The phenazine series. Part VI. Reactions of alkyl phenazonium salts; the phenazyls , 1937 .
[64] F. Kehrmann,et al. Zur Kenntnis des Phenazins , 1913 .